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The synthesised biobased calcium carbonate nanocrystals had demonstrated to be an effective 
carrier for delivery of anticancer drug doxorubicin (DOX). The use of these nanocrystals 
displayed high levels of selectivity and specificity in achieving effective cancer cell death 
without nonspecific toxicity. These results confirmed that DOX was intercalated into calcium 
carbonate nanocrystals at high loading and encapsulation efficiency (4.8 and 96%, resp.). The 
CaCO₃/DOX nanocrystals are relatively stable at neutral pH (7.4), resulting in slow release, 
but the nanocrystals progressively dissociated in acidic pH (4.8) regimes, triggering faster 
release of DOX. The CaCO₃/DOX nanocrystals exhibited high uptake by MDA MB231 
breast cancer cells and a promising potential delivery of DOX to target cells. In vitro 
chemosensitivity using MTT, modified neutral red/trypan blue assay, and LDH on MDA 
MB231 breast cancer cells revealed that CaCO₃/DOX nanocrystals are more sensitive and 
gave a greater reduction in cell growth than free DOX. Our findings suggest that CaCO₃ 
nanocrystals hold tremendous promise in the areas of controlled drug delivery and targeted 
cancer therapy. 
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